IN8bio, Inc. (INAB) DCF Valuation

IN8bio, Inc. (INAB) DCF Valuation
  • ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
  • ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
  • ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
  • ✓ No Se Necesita Experiencia; Fáciles De Seguir

IN8bio, Inc. (INAB) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Simplify IN8bio, Inc. (INAB) valuation with this customizable DCF Calculator! Featuring real IN8bio, Inc. (INAB) financials and adjustable forecast inputs, you can test scenarios and uncover IN8bio, Inc. (INAB) fair value in minutes.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Revenue Growth, % 0 0 0 0 0 0 0 0 0 0
EBITDA -5.0 -8.5 -14.4 -27.4 -28.5 .0 .0 .0 .0 .0
EBITDA, % 100 100 100 100 100 100 100 100 100 100
Depreciation .1 .1 .3 1.1 1.8 .0 .0 .0 .0 .0
Depreciation, % 100 100 100 100 100 100 100 100 100 100
EBIT -5.1 -8.6 -14.7 -28.5 -30.3 .0 .0 .0 .0 .0
EBIT, % 100 100 100 100 100 100 100 100 100 100
Total Cash .6 18.0 37.0 18.2 21.3 .0 .0 .0 .0 .0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 .0 .0 .0 .0
Account Receivables, % 100 100 100 100 100
Inventories .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Inventories, % 100 100 100 100 100 100 100 100 100 100
Accounts Payable .6 .6 .4 2.1 .9 .0 .0 .0 .0 .0
Accounts Payable, % 100 100 100 100 100 100 100 100 100 100
Capital Expenditure -.3 .0 -.3 -3.7 -.6 .0 .0 .0 .0 .0
Capital Expenditure, % 100 100 100 100 100 0 0 0 0 0
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -5.1 -8.6 -14.7 -27.4 -30.3 .0 .0 .0 .0 .0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -4.8 -8.4 -14.9 -28.3 -30.3 -.9 .0 .0 .0 .0
WACC, % 5.04 5.04 5.04 4.97 5.04 5.02 5.02 5.02 5.02 5.02
PV UFCF
SUM PV UFCF -.9
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 0
Present Terminal Value 0
Enterprise Value -1
Net Debt -16
Equity Value 16
Diluted Shares Outstanding, MM 30
Equity Value Per Share 0.52

What You Will Get

  • Real INAB Financial Data: Pre-filled with IN8bio’s historical and projected data for precise analysis.
  • Fully Editable Template: Modify key inputs like revenue growth, WACC, and EBITDA % with ease.
  • Automatic Calculations: See IN8bio’s intrinsic value update instantly based on your changes.
  • Professional Valuation Tool: Designed for investors, analysts, and consultants seeking accurate DCF results.
  • User-Friendly Design: Simple structure and clear instructions for all experience levels.

Key Features

  • Comprehensive INAB Data: Pre-loaded with IN8bio's historical financial performance and future projections.
  • Customizable Financial Inputs: Modify revenue growth rates, profit margins, discount rates, tax assumptions, and capital investment figures.
  • Interactive Valuation Model: Instant recalculations of Net Present Value (NPV) and intrinsic value based on user-defined parameters.
  • Multiple Scenario Analysis: Develop various forecasting scenarios to evaluate differing valuation results.
  • Intuitive User Interface: Clean, organized layout suitable for both seasoned professionals and newcomers.

How It Works

  1. Step 1: Download the Excel file.
  2. Step 2: Review IN8bio, Inc.'s pre-filled financial data and forecasts.
  3. Step 3: Modify critical inputs like revenue growth, WACC, and tax rates (highlighted cells).
  4. Step 4: Watch the DCF model update instantly as you tweak assumptions.
  5. Step 5: Analyze the outputs and use the results for investment decisions.

Why Choose the IN8bio, Inc. (INAB) Calculator?

  • Accuracy: Utilizes real IN8bio financial data for precise calculations.
  • Flexibility: Tailored for users to easily test and adjust inputs as needed.
  • Time-Saving: Eliminate the tedious process of creating a financial model from the ground up.
  • Professional-Grade: Crafted with the expertise and usability expected at the CFO level.
  • User-Friendly: Intuitive design makes it accessible for users without extensive financial modeling skills.

Who Should Use This Product?

  • Investors: Evaluate IN8bio, Inc. (INAB) to make informed decisions on buying or selling shares.
  • CFOs and Financial Analysts: Optimize valuation methodologies and assess financial forecasts for IN8bio, Inc. (INAB).
  • Startup Founders: Discover valuation strategies by examining how companies like IN8bio, Inc. (INAB) are assessed.
  • Consultants: Create detailed valuation reports for clients based on insights from IN8bio, Inc. (INAB).
  • Students and Educators: Utilize current data from IN8bio, Inc. (INAB) to enhance learning and teaching of valuation principles.

What the Template Contains

  • Operating and Balance Sheet Data: Pre-filled IN8bio, Inc. (INAB) historical data and forecasts, including revenue, EBITDA, EBIT, and capital expenditures.
  • WACC Calculation: A dedicated sheet for Weighted Average Cost of Capital (WACC), including parameters like Beta, risk-free rate, and share price.
  • DCF Valuation (Unlevered and Levered): Editable Discounted Cash Flow models showing intrinsic value with detailed calculations.
  • Financial Statements: Pre-loaded financial statements (annual and quarterly) to support analysis.
  • Key Ratios: Includes profitability, leverage, and efficiency ratios for IN8bio, Inc. (INAB).
  • Dashboard and Charts: Visual summary of valuation outputs and assumptions to analyze results easily.

No products were found matching.